The Pistoia Alliance in collaboration with QED-C, QuPharm, and QPARC has been hosting a monthly Community of Interest Meeting bringing together the Quantum Computing (QC) Experts from the Pharma and QC Industries to explore the potential of this new technology on the pharmaceutical industry.
Despite much ‘hype’ around how quantum computers will potentially revolutionize drug discovery, the precise pharma use cases wherein a quantum advantage will be someday demonstrable relative to classical computing have remained somewhat a mystery to the larger pharma/life science community. The goal of this event is to ‘bridge the gap’ between quantum experts and the rest of the pharma/life science industry with presentations from many of the top pharma quantum computing practitioners who will explain the work they have been doing, which type of problems are amenable to QC, conclusions based on existing technology, and anticipated benefits to using QC with future technological advancements.
The Pistoia Alliance would like to thank TerraQuantum for kindly sponsoring this event.
Speakers
John Wise, Consultant, Pistoia Alliance: Brief Introduction to the Pistoia Alliance / QED-C / QuPharm / QPARC Quantum Computing for the Pharmaceutical Industry – Community of Interest (10 min).
Vishal Shete, Director, TerraQuantum: The role of QC in Biology and potential near-term use cases
Thomas Ehmer, Business Technologies R&D Science and Technology – Innovation Incubator, Merck Group: Quantum Computing for Natural Language Processing and Clinical Trial Optimisation (10 min).
Zoran Krunic, Sr. Manager Data Science, R&D, Amgen: Quantum Computing for Electronic Health Records
Yvonne Li, Research Informatics Scientist, Roche: Quantum Machine Learning Use Cases in Roche pRED.
The Future of Biology is Quantum Whitepaper
Agenda
| 16:00 | Welcome and Introductory remarks:
|
| 16:15 | · Thomas Ehmer, Business Technologies R&D Science and Technology – Innovation Incubator, Merck Group
o Optimisation beyond quantum chemistry – exploration of two cases for potential value of Quantum computing in later clinical phases: QNLP for AE detection and clinical trial modelling optimization |
| 16:30 | · Yvonna Li, Research Informatics Scientist, Roche
o Roche: Some interesting ML Use Cases |
| 16:45 | · Vishal Shete, Director of Strategy, Terra Quantum (Sponsor)
o The role of QC in Biology and potential near-term use cases |
| 17:00 | · Zoran Krunic, Sr. Manager Data Science, R&D, Amgen
o Quantum Computing for Electronic Health Records |
| 17:20 | Concluding Remarks |